Leland W.K. Chung

48.6k total citations · 5 hit papers
532 papers, 29.8k citations indexed

About

Leland W.K. Chung is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Leland W.K. Chung has authored 532 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Pulmonary and Respiratory Medicine, 156 papers in Molecular Biology and 132 papers in Pathology and Forensic Medicine. Recurrent topics in Leland W.K. Chung's work include Prostate Cancer Treatment and Research (153 papers), Systemic Sclerosis and Related Diseases (109 papers) and Inflammatory Myopathies and Dermatomyositis (59 papers). Leland W.K. Chung is often cited by papers focused on Prostate Cancer Treatment and Research (153 papers), Systemic Sclerosis and Related Diseases (109 papers) and Inflammatory Myopathies and Dermatomyositis (59 papers). Leland W.K. Chung collaborates with scholars based in United States, China and Canada. Leland W.K. Chung's co-authors include Shuming Nie, Haiyen E. Zhau, Xiaohu Gao, Yuanyuan Cui, Richard M. Levenson, David Fiorentino, Gerald R. Cunha, Andrew C. von Eschenbach, Robert A. Sikes and Jer‐Tsong Hsieh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Leland W.K. Chung

522 papers receiving 29.2k citations

Hit Papers

In vivo cancer targeting and imaging with semiconductor ... 1992 2026 2003 2014 2004 1992 1994 2011 2011 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In vivo cancer targeting and imaging with semiconductor quantum dots
    2004 3.8k citations Leland W.K. Chung et al. profile →
  2. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
    1992 916 citations Leland W.K. Chung et al. PubMed profile →
  3. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
    1994 626 citations Ploutarchos Anezinis, Haiyen E. Zhau et al. PubMed profile →
  4. Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
    2011 542 citations Jian Liu, Leland W.K. Chung et al. profile →
  5. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
    2011 371 citations David Fiorentino, Leland W.K. Chung et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leland W.K. Chung United States 88 11.7k 9.0k 6.7k 4.4k 3.9k 532 29.8k
Ralph R. Weichselbaum United States 107 17.9k 1.5× 10.6k 1.2× 18.7k 2.8× 7.6k 1.7× 1.8k 0.5× 707 48.4k
Harold F. Dvorak United States 101 24.4k 2.1× 5.1k 0.6× 10.0k 1.5× 10.0k 2.3× 1.6k 0.4× 279 47.8k
Philip S. Low United States 96 15.7k 1.3× 4.7k 0.5× 4.7k 0.7× 1.7k 0.4× 621 0.2× 521 36.9k
Jian Wang China 79 14.5k 1.2× 3.5k 0.4× 5.6k 0.8× 6.6k 1.5× 1.0k 0.3× 1.1k 28.6k
Lisa M. Coussens United States 81 23.6k 2.0× 6.3k 0.7× 27.4k 4.1× 12.5k 2.9× 2.0k 0.5× 198 61.3k
Kohei Miyazono Japan 123 41.5k 3.6× 4.6k 0.5× 12.8k 1.9× 8.3k 1.9× 3.5k 0.9× 463 57.4k
Daniel D. Von Hoff United States 91 19.7k 1.7× 6.7k 0.7× 23.6k 3.5× 8.3k 1.9× 2.7k 0.7× 821 44.9k
Toshikazu Nakamura Japan 96 11.2k 1.0× 2.6k 0.3× 3.8k 0.6× 2.0k 0.5× 1.6k 0.4× 844 37.6k
Wim J.G. Oyen Netherlands 87 5.8k 0.5× 6.2k 0.7× 7.2k 1.1× 2.1k 0.5× 1.0k 0.3× 689 30.8k
Doménico Ribatti Italy 93 17.8k 1.5× 3.2k 0.4× 8.6k 1.3× 5.8k 1.3× 2.2k 0.6× 872 35.3k

Countries citing papers authored by Leland W.K. Chung

Since Specialization
Citations

This map shows the geographic impact of Leland W.K. Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leland W.K. Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leland W.K. Chung more than expected).

Fields of papers citing papers by Leland W.K. Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leland W.K. Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leland W.K. Chung. The network helps show where Leland W.K. Chung may publish in the future.

Co-authorship network of co-authors of Leland W.K. Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Leland W.K. Chung. A scholar is included among the top collaborators of Leland W.K. Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leland W.K. Chung. Leland W.K. Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Leland W.K., et al.. (2025). Generative modelling of financial time series with structured noise and MMD-based signature learning. Statistics & Risk Modeling. 42(3-4). 91–122.
2.
Oldroyd, Alexander, Jeffrey P. Callen, Hector Chinoy, et al.. (2021). Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Lara D. Veeken. 60(11). 5483–5483. 4 indexed citations
3.
Oldroyd, Alexander, Jeffrey P. Callen, Hector Chinoy, et al.. (2021). A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Lara D. Veeken. 60(6). 2615–2628. 87 indexed citations
4.
Yin, Liyuan, Yi Zhang, Lijuan Yin, et al.. (2021). Novel Mitochondria-Based Targeting Restores Responsiveness in Therapeutically Resistant Human Lung Cancer Cells. Molecular Cancer Therapeutics. 20(12). 2527–2538. 6 indexed citations
5.
Hsieh, Chia‐Ling, et al.. (2019). A Novel Salicylanilide Derivative Induces Autophagy Cell Death in Castration-Resistant Prostate Cancer via ER Stress-Activated PERK Signaling Pathway. Molecular Cancer Therapeutics. 19(1). 101–111. 24 indexed citations
6.
Lin, Tzu‐Ping, Jingjing Li, Qinlong Li, et al.. (2018). R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc. Molecular Cancer Research. 16(12). 1940–1951. 14 indexed citations
7.
Nandana, Srinivas, Manisha Tripathi, Peng Duan, et al.. (2017). Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2–WNT Signaling Axis. Cancer Research. 77(6). 1331–1344. 54 indexed citations
8.
Josson, Sajni, Murali Gururajan, Peizhen Hu, et al.. (2014). miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer. Clinical Cancer Research. 20(17). 4636–4646. 118 indexed citations
9.
Gururajan, Murali, Sajni Josson, Gina Chia‐Yi Chu, et al.. (2014). miR-154* and miR-379 in the DLK1-DIO3 MicroRNA Mega-Cluster Regulate Epithelial to Mesenchymal Transition and Bone Metastasis of Prostate Cancer. Clinical Cancer Research. 20(24). 6559–6569. 82 indexed citations
10.
Barst, Robyn J., Leland W.K. Chung, Roham T. Zamanian, Michelle Turner, & Michael D. McGoon. (2013). Functional Class Improvement and 3-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL Registry. CHEST Journal. 144(1). 160–168. 69 indexed citations
11.
Freeman, Michael R., Quanlin Li, & Leland W.K. Chung. (2013). Can Stroma Reaction Predict Cancer Lethality?. Clinical Cancer Research. 19(18). 4905–4907. 19 indexed citations
12.
Zhang, Dong, Dalin He, Yan Xue, et al.. (2011). PrLZ Protects Prostate Cancer Cells from Apoptosis Induced by Androgen Deprivation via the Activation of Stat3/Bcl-2 Pathway. Cancer Research. 71(6). 2193–2202. 37 indexed citations
13.
Huang, Wen‐Chin, Xiangyan Li, Jian Liu, Jen‐Tai Lin, & Leland W.K. Chung. (2011). Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells. Molecular Cancer Research. 10(1). 133–142. 193 indexed citations
14.
Yang, Xiaojian, Chunmeng Shi, Rong Tong, et al.. (2010). Near IR Heptamethine Cyanine Dye–Mediated Cancer Imaging. Clinical Cancer Research. 16(10). 2833–2844. 259 indexed citations
15.
Sung, Shian‐Ying, Chia‐Ling Hsieh, Andrew M. K. Law, et al.. (2008). Coevolution of Prostate Cancer and Bone Stroma in Three-Dimensional Coculture: Implications for Cancer Growth and Metastasis. Cancer Research. 68(23). 9996–10003. 124 indexed citations
16.
Huang, Wen‐Chin, Jonathan J. Havel, Haiyen E. Zhau, et al.. (2008). β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells. Clinical Cancer Research. 14(17). 5341–5347. 35 indexed citations
17.
Chung, Leland W.K., et al.. (2007). Prostate Cancer. Humana Press eBooks. 3 indexed citations
18.
Chan, Tzu-Liang, ST Yuen, Leland W.K. Chung, et al.. (1999). Frequent Microsatellite Instability and Mismatch Repair Gene Mutations in Young Chinese Patients With Colorectal Cancer. JNCI Journal of the National Cancer Institute. 91(14). 1221–1226. 44 indexed citations
19.
Marengo, Susan Ruth, Robert A. Sikes, Ploutarchos Anezinis, Shi‐Ming Chang, & Leland W.K. Chung. (1997). Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE). Molecular Carcinogenesis. 19(3). 165–175. 18 indexed citations
20.
Freeman, Michael R., Robert Washecka, & Leland W.K. Chung. (1989). Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers.. PubMed. 49(22). 6221–5. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralph R. Weichselbaum Breakdown of academic impact, for papers by Harold F. Dvorak Breakdown of academic impact, for papers by Philip S. Low Breakdown of academic impact, for papers by Jian Wang Breakdown of academic impact, for papers by Lisa M. Coussens Breakdown of academic impact, for papers by Kohei Miyazono Breakdown of academic impact, for papers by Daniel D. Von Hoff Breakdown of academic impact, for papers by Toshikazu Nakamura Breakdown of academic impact, for papers by Wim J.G. Oyen Breakdown of academic impact, for papers by Doménico Ribatti
Rankless by CCL
2026